Incorporating systems thinking into drug value assessment promises more realistic evaluations of the impact of new therapies, ...
Health Affairs' Senior Deputy Editor Rob Lott interviews Richard Leuchter from the University of California Los Angeles on ...
In the less than two months since inauguration, President Trump and his administration have issued a dizzying array of health ...
President Trump campaigned on leaving the issue of abortion up to state policymakers. However, his administration has already ...
Potential Medicare coverage reforms, such as eliminating Coverage with Evidence Development, would remove key policy tools ...
Recent policy directives from the White House seek to compel actions that are contrary to widely accepted standards of ...
The argument for continuing the Acute Hospital Care at Home waiver and expanding access to Hospital at Home only becomes ...
By establishing a Medicare PPS methodology for CCBHCs, CMS can provide the financial stability needed to expand service ...
There is considerable risk that a federal Medicaid work requirement would cause many people with substance use disorder to ...
While there are some reasons for optimism, if the experience of the last few weeks is a sign of what is to come, the already ...
As cancer care has evolved to include more sophisticated therapies such as targeted treatments and immunotherapy, the ...
Amidst the nation’s fentanyl crisis, the federal exemptions made special allowances for buprenorphine, specifically allowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results